References
Brodsky MB, Pandian V, Needham DM (2020) Post-extubation dysphagia: a problem needing multidisciplinary efforts. Intensive Care Med 46(1):93–96. https://doi.org/10.1007/s00134-019-05865-x
Schefold JC, Berger D, Zurcher P, Lensch M, Perren A, Jakob SM, Parviainen I, Takala J (2017) Dysphagia in mechanically ventilated ICU patients (DYnAMICS): a prospective observational trial. Crit Care Med 45(12):2061–2069
Marian T, Dunser M, Citerio G, Kokofer A, Dziewas R (2018) Are intensive care physicians aware of dysphagia? The MAD(ICU) survey results. Intensive Care Med 44(6):973–975
Zuercher P, Moret CS, Dziewas R, Schefold JC (2019) Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. Crit Care 23(1):103
Dziewas R, Stellato R, van der Tweel I, Walther E, Werner CJ, Braun T, Citerio G, Jandl M, Friedrichs M, Notzel K et al (2018) Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial. Lancet Neurol 17(10):849–859
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The Department of Intensive Care Medicine (PZ, JCS) has/ had research & development/ consulting contracts with (full disclosure): Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH/ SA, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, and Nestlé. Educational grants have been received from Fresenius Kabi; GSK; MSD; Lilly; Baxter; Astellas; AstraZeneca; B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma), Phagenesis, Pfizer, Orion Pharma. No personal financial gain resulted from respective development/ consulting contracts and/or grants. JCS is principle investigator of the PHINEST study. The University Hospital Münster received case money in the PHAST TRAC-trial and the “Pharyngeal electrical stimulation for treatment of neurogenic dysphagia: a European Registry (PHADER)” study. RD has received travel expenses in his role as principal investigator in PHAST-TRAC and PHADER from Phagenesis Ltd. RD also received honoraria for serving as a consultant for Nestlé Health Science and worked as non-paid adviser for the company Phagenesis Ltd.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zuercher, P., Dziewas, R. & Schefold, J.C. Dysphagia in the intensive care unit: a (multidisciplinary) call to action. Intensive Care Med 46, 554–556 (2020). https://doi.org/10.1007/s00134-020-05937-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-05937-3